450 Participants Needed

Implementation Support Strategies for Disruptive Behaviors

(SKIPforPA Trial)

Recruiting at 1 trial location
KM
SM
ON
SI
Overseen BySatish Iyengar, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests strategies to improve the use of a treatment for childhood disruptive behaviors and ADHD in pediatric primary care offices. The treatment, known as Doctor Office Collaborative Care (DOCC), has already shown positive results in managing these issues. The trial will compare different ways to implement DOCC, such as providing extra support to practice leaders or care teams, to determine the most effective approach. Caregivers of children aged 5-12 with noticeable behavior problems would be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative strategies that could enhance care for children with behavioral challenges.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that Doctor Office Collaborative Care (DOCC) safely manages childhood behavior issues and ADHD. Studies have found that DOCC results in a high number of children starting and completing treatment. Specifically, 99.4% of children began treatment, and 76.6% completed it, indicating the treatment's positive reception.

Moreover, DOCC has led to significant improvements in children's behavior and emotions, underscoring its effectiveness and safety. No major reports of negative side effects have emerged, making it a promising option for those considering participation in a clinical trial.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because they aim to enhance the implementation of DOCC, an evidence-based approach for managing disruptive behavior and ADHD. Unlike typical treatments that may lack structured support post-training, these strategies provide targeted support for practice leadership (LEAD) and care teams (TEAM), potentially increasing effectiveness. By providing tailored implementation support, these treatments might improve how DOCC is adopted and sustained in clinical settings, leading to better patient outcomes.

What evidence suggests that this trial's treatments could be effective for managing disruptive behavior and ADHD?

Research has shown that the Doctor Office Collaborative Care (DOCC) model effectively manages childhood behavior problems and ADHD. Studies have found that children are more likely to start and complete treatment with DOCC compared to regular care—99.4% start with DOCC versus 54.2% with usual care, and 76.6% complete treatment with DOCC versus 11.6% with usual care. DOCC also reduces oppositional behaviors and improves symptoms of oppositional defiant disorder (ODD) and overall quality of life over time. This model involves both the child and parent in behavioral therapy, a proven method for addressing disruptive behavior issues. The consistent improvements in clinical outcomes demonstrate DOCC's effectiveness in these areas. In this trial, participants will receive DOCC with varying levels of implementation support, including standard implementation, TEAM implementation, LEAD implementation, or both TEAM and LEAD implementation, to assess the impact of these support strategies on the effectiveness of DOCC.12567

Who Is on the Research Team?

DJ

David J Kolko, PhD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for caregivers with a child aged 5-12 showing behavior problems, and staff at selected pediatric practices in PA. Staff roles include primary care providers, care managers, medical directors/senior leaders, and practice managers.

Inclusion Criteria

SL Participants: Employed at one of the up to twenty-four (24) pediatric primary care practices identified by the PA Medical Home Program at the PA AAP or by the University of Pittsburgh research team. Identified by the practice as the Senior Leader. Have a practice-level leadership role such as Medical Director or a clinical/practice leader. Have administrative responsibilities related to patient care and/or the operations/management of the practice.
I am a Practice Manager at a pediatric care practice selected for the study.
PCP Participants: Employed at one of the up to twenty-four (24) pediatric primary care practices identified by the PA Medical Home Program at the PA AAP or by the University of Pittsburgh research team. Identified by the practice as a Primary Care Provider
See 2 more

Exclusion Criteria

Caregivers: Already enrolled in the study as the caregiver to a different child (e.g., sibling)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Standard training in the DOCC evidence-based practice (EBP) for all practices

4 weeks

Implementation

Implementation of DOCC with various support strategies (TEAM, LEAD, or both) delivered via videoconference

24 months
Regular videoconference sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • DOCC: Evidence-based treatment for disruptive behavior and ADHD
  • Implementation support strategies at the leadership level following standard implementation of DOCC
  • TEAM: Implementation support strategies at the care team level following standard implementation of DOCC
Trial Overview The study tests if extra support strategies for teams and leadership can improve the use of DOCC—an effective treatment program for childhood behavior issues and ADHD—in various pediatric offices.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: DOCC with TEAM implementationExperimental Treatment2 Interventions
Group II: DOCC with TEAM + LEAD implementationExperimental Treatment3 Interventions
Group III: DOCC with LEAD implementationExperimental Treatment2 Interventions
Group IV: DOCC with standard implementation (No TEAM or LEAD)Active Control1 Intervention

DOCC: Evidence-based treatment for disruptive behavior and ADHD is already approved in United States for the following indications:

🇺🇸
Approved in United States as DOCC for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Pennsylvania American Academy of Pediatrics

Collaborator

Trials
2
Recruited
480+

NYU Langone Health

Collaborator

Trials
1,431
Recruited
838,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Pennsylvania Chapter American Academy of Pediatrics

Collaborator

Trials
1
Recruited
450+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

American Academy of Pediatrics

Collaborator

Trials
46
Recruited
4,071,000+

Drexel University

Collaborator

Trials
160
Recruited
48,600+

Published Research Related to This Trial

This study aims to improve the implementation of an evidence-based practice for treating Oppositional Defiant Disorder (ODD) in children, particularly in public mental health clinics serving low-income communities, involving 134 clinics and nearly 2700 caregiver/child pairs.
The research will assess how a Clinic Implementation Team (CIT) can enhance the uptake and long-term use of the 4Rs and 2Ss Multiple Family Group intervention, potentially increasing access to effective treatments for children with ODD.
Testing the 4Rs and 2Ss Multiple Family Group intervention: study protocol for a randomized controlled trial.Acri, M., Hamovitch, E., Mini, M., et al.[2019]
Clinicians believe that the success of parent-directed behavioral therapy (PDT) for disruptive behavior disorders in children is significantly influenced by appointment attendance and the primary caregiver's commitment to the treatment approach.
Additional factors affecting PDT effectiveness include the caregiver's support system, emotional and physical well-being, the complexity of the child's behavior, and the home environment, suggesting that improving these areas could enhance treatment outcomes.
Clinician-Identified Factors in Success of Parent-Directed Behavioral Therapy for Children's Tantrums.Yu-Lefler, HF., Lindauer, S., Riley, AW.[2022]
In a study of 659 families with children diagnosed with ADHD, it was found that children had a median of only one follow-up visit with their primary care clinician over six months, indicating a need for more consistent follow-up care.
Only 26% of children saw a mental health specialist, highlighting a gap in specialized care, although those with certain demographics, like being black or on Medicaid, were more likely to receive this support.
Follow-up care of children identified with ADHD by primary care clinicians: A prospective cohort study.Gardner, W., Kelleher, KJ., Pajer, K., et al.[2018]

Citations

Collaborative Care Outcomes for Pediatric Behavioral ...DOCC (versus EUC) was associated with higher rates of treatment initiation (99.4% vs 54.2%; P < .001) and completion (76.6% vs 11.6%, P < .001), improvement in ...
Doctor-Office Collaborative Care for Pediatric Behavioral ...Improvements in clinical outcomes were found for both conditions, but DOCC showed significantly greater reductions in oppositionality, ...
Effectiveness of Collaborative Services in Primary Care for ...Behavioral therapy that targets parent and child skills has shown to be the most effective treatment for DBP. This study will evaluate the effectiveness of a ...
Effects of Collaborative Care for Comorbid Attention Deficit ...Point-in-time contrasts showed that DOCC cases showed significant improvement in ODD symptoms and quality of life at 12 months and at 18 months; DOCC cases only ...
Implementation Support Strategies for Disruptive BehaviorsThe doctor-office collaborative care (DOCC) model was found to be effective for treating pediatric behavior problems and ADHD, showing improved clinical ...
NCT04946253 | SKIP for PA Study: Team and Leadership ...The treatment investigators seek to deliver here is called Doctor Office Collaborative Care (DOCC), an evidence-based intervention for the management of child ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/22064876/
Doctor-office collaborative care for pediatric behavioral ...Results: Group comparisons found significant improvements for DOCC over EUC in service use and completion, behavioral and emotional problems, individualized ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security